TruFUSE(R) Patents Awarded

CLEARWATER, Fla., July 8 /PRNewswire/ -- minSURG(TM) Corporation, through its parent company, Orthopedic Development Corporation, has received a Notice of Allowance from the United States Patent and Trademark Office on two of its pending US patent applications. The patents protect the designs of one of its TruFUSE(R) dowels and a Surgical Drill Guide, which is used in minSURG's proprietary TruFUSE Minimally Invasive Facet Fusion Procedures and Systems. The pending patents, once issued, will offer patent protection through 2022.

Six additional patent applications related to the TruFUSE product remain pending. TruFUSE uses specially designed bone dowels to stop facet joints from moving, which is intended to eliminate or dramatically reduce back pain caused by a variety of reasons. TruFUSE is also used to supplement other back surgeries when more invasive or destructive means are not required. The TruFUSE procedure is intended to fuse the facet joints through a natural healing process for a long-term solution. Because TruFUSE causes minimal tissue damage, it does not preclude other options, including non-surgical alternatives, and TruFUSE can be used earlier than other, more invasive spine fusion methods.

For more information on TruFUSE, please visit the Web site at www.trufuse.com or call (813) 318-0565 ext. 216.